Diagnostic interobserver variability in Crohn's disease- and ulcerative colitis-associated dysplasia: a multicenter digital survey from the IG-IBD Pathologists Group.
Crohn’s disease
Dysplasia
Inflammatory bowel disease
Ulcerative colitis
Journal
Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
28
05
2020
accepted:
23
09
2020
pubmed:
8
10
2020
medline:
28
4
2021
entrez:
7
10
2020
Statut:
ppublish
Résumé
Crohn's disease (CD) and ulcerative colitis, two forms of inflammatory bowel disease (IBD), are chronic and relapsing conditions of the gastrointestinal tract both characterized by long lasting chronic inflammation and increased risk of dysplasia and colorectal cancer (CRC). The aim of our study was to evaluate the interobserver agreement about IBD-associated dysplasia among pathologists belonging to the Italian Group for Inflammatory Bowel Diseases (IG-IBD P). The present multicenter survey was performed using telepathology, supported by an open source E-learning platform. Biopsy specimens from 30 colonoscopies and from 20 patients were included. The glass slides of any case, including clinical and endoscopic data, were digitalized and uploaded on the E-learning platform. All the digital slides were grouped in 54 diagnostic "blocks". Blinded histopathological evaluation on all the digital slides was performed by 20 gastrointestinal pathologists. Closed-ended questions about (1) the occurrence of IBD; (2) the classification of IBD (as UC or CD); (3) the presence of active versus quiescent disease; (4) the presence of dysplasia; (5) the possible association of dysplasia with the sites of disease (dysplasia-associated lesion or mass-DALM vs adenoma-like mass-ALM); (6) the grading of dysplasia according to the ECCO guidelines (negative, indefinite, low grade, high grade categories) and (7) the presence of associated serrated features, were proposed in each case. Inter-observer agreement was evaluated by mean agreement percentage and kappa statistic, when suitable. The diagnosis of IBD was confirmed in 19 of 20 patients, 17 of 19 being classified as UC, 2 as CD. The mean interobserver agreement percentages about (1) the evidence of IBD, (2) the presence of either UC or CD and (3) the activity grading resulted to be 80%, 69% and 86%, respectively. Dysplasia was detected in 8/20 patients, with moderate agreement between pathologists (mean 72%, k 0.48). Particularly, low grade dysplasia was found in 13 biopsies (combined k 0.38), whereas high grade dysplasia in 8 (combined k 0.47). When the endoscopic and histopathological data were combined, features consistent with DALM were found in 6 of 20 patients with low grade dysplasia and those consistent with ALM in 2 patients with low grade dysplasia in a single biopsy (mean agreement: 86%). An associated serrated pattern was discovered in 4 patients (7 biopsies). Our study showed moderate interobserver agreement about the histopathological detection and classification of IBD-associated dysplasia. Further efforts should be undertaken to integrate the histopathological data with both the ancillary tests and molecular investigations.
Sections du résumé
BACKGROUND
Crohn's disease (CD) and ulcerative colitis, two forms of inflammatory bowel disease (IBD), are chronic and relapsing conditions of the gastrointestinal tract both characterized by long lasting chronic inflammation and increased risk of dysplasia and colorectal cancer (CRC). The aim of our study was to evaluate the interobserver agreement about IBD-associated dysplasia among pathologists belonging to the Italian Group for Inflammatory Bowel Diseases (IG-IBD P).
METHODS
The present multicenter survey was performed using telepathology, supported by an open source E-learning platform. Biopsy specimens from 30 colonoscopies and from 20 patients were included. The glass slides of any case, including clinical and endoscopic data, were digitalized and uploaded on the E-learning platform. All the digital slides were grouped in 54 diagnostic "blocks". Blinded histopathological evaluation on all the digital slides was performed by 20 gastrointestinal pathologists. Closed-ended questions about (1) the occurrence of IBD; (2) the classification of IBD (as UC or CD); (3) the presence of active versus quiescent disease; (4) the presence of dysplasia; (5) the possible association of dysplasia with the sites of disease (dysplasia-associated lesion or mass-DALM vs adenoma-like mass-ALM); (6) the grading of dysplasia according to the ECCO guidelines (negative, indefinite, low grade, high grade categories) and (7) the presence of associated serrated features, were proposed in each case. Inter-observer agreement was evaluated by mean agreement percentage and kappa statistic, when suitable.
RESULTS
The diagnosis of IBD was confirmed in 19 of 20 patients, 17 of 19 being classified as UC, 2 as CD. The mean interobserver agreement percentages about (1) the evidence of IBD, (2) the presence of either UC or CD and (3) the activity grading resulted to be 80%, 69% and 86%, respectively. Dysplasia was detected in 8/20 patients, with moderate agreement between pathologists (mean 72%, k 0.48). Particularly, low grade dysplasia was found in 13 biopsies (combined k 0.38), whereas high grade dysplasia in 8 (combined k 0.47). When the endoscopic and histopathological data were combined, features consistent with DALM were found in 6 of 20 patients with low grade dysplasia and those consistent with ALM in 2 patients with low grade dysplasia in a single biopsy (mean agreement: 86%). An associated serrated pattern was discovered in 4 patients (7 biopsies).
CONCLUSIONS
Our study showed moderate interobserver agreement about the histopathological detection and classification of IBD-associated dysplasia. Further efforts should be undertaken to integrate the histopathological data with both the ancillary tests and molecular investigations.
Identifiants
pubmed: 33025294
doi: 10.1007/s10151-020-02349-9
pii: 10.1007/s10151-020-02349-9
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
101-108Investigateurs
L Albarello
(L)
A Andorno
(A)
M R Aprile
(MR)
M C Aquilano
(MC)
L Baron
(L)
S Battista
(S)
G Becchina
(G)
D Bellis
(D)
E Biletta
(E)
M R D'Ambrosio
(MR)
E David
(E)
R Del Sordo
(R)
M Facchetti
(M)
M Fortunato
(M)
M C Giustiniani
(MC)
D Piscitelli
(D)
L Saragoni
(L)
G Tanzi
(G)
Références
Molodecky NA, Soon IS, Rabi DM et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time. Based Syst Rev Gastroenterol 142(1):46–54
Feuerstein JD, Cheifetz AS (2014) Ulcerative colitis: epidemiology, diagnosis, and management review. Mayo Clin Proc 89(11):1553–1563
doi: 10.1016/j.mayocp.2014.07.002
Ananthakrishnan AN (2015) Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60(2):290–298
doi: 10.1007/s10620-014-3350-9
Lee D, Albenberg L, Compher C et al (2015) Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 148(6):1087–1106
doi: 10.1053/j.gastro.2015.01.007
Jess T, Simonsen J, Jørgensen KT et al (2012) Decreasing risk of colorectal cancer in patients with IBD over 30 years. Gastroenterology 143(2):375–381
doi: 10.1053/j.gastro.2012.04.016
Herrinton LJ, Liu L, Levin TR et al (2012) Incidence and mortality of colorectal adenocarcinoma in persons with IBD from 1998 to 2010. Gastroenterology 143:382–389
doi: 10.1053/j.gastro.2012.04.054
De Jong ME, Kanne H, Nissen LHC et al (2020) Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia. Gastrointest Endosc 91(6):1334–1342.e1
doi: 10.1016/j.gie.2019.12.041
Zhang YZ, Li YY (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20(1):91–99
doi: 10.3748/wjg.v20.i1.91
Quetglas EG, Mujagic Z, Wigge S et al (2015) Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease. World J Gastroenterol 21(44):12519–12543
doi: 10.3748/wjg.v21.i44.12519
Beaugerie L, Itzkowitz SH (2015) Cancers complicating inflammatory bowel disease. Rev N Engl J Med 372(15):1441–1452
doi: 10.1056/NEJMra1403718
Svrcek M, Borralho Nunes P, Villanacci V et al (2018) Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: the role of inflammation. J Crohns Colitis 12(12):1486–1498
pubmed: 30202940
Laine L, Kaltenbach T, Barkun A et al (2015) SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 81(3):489–501
doi: 10.1016/j.gie.2014.12.009
Magro F, Langner C, Driessen A et al (2013) European consensus on the histopathology of IBD. J Crohns Colitis 7(10):827–851
doi: 10.1016/j.crohns.2013.06.001
Schlemper RJ, Riddell RH, Kato Y et al (2000) The vienna classification of gastrointestinal epithelial neoplasia. Gut 47(2):251–255
doi: 10.1136/gut.47.2.251
Riddell RH, Goldman H, Ransohoff DF et al (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14(11):931–968
doi: 10.1016/S0046-8177(83)80175-0
Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis 11(1):3–25
doi: 10.1093/ecco-jcc/jjw168
Feakins RM, British Society of Gastroenterology (2013) IBD biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol 66(12):1005–1026
doi: 10.1136/jclinpath-2013-201885
Harpaz N, Polydorides AD (2010) Colorectal dysplasia in chronic IBD: pathology, clinical implications, and pathogenesis. Arch Pathol Lab Med 134(6):876–895
pubmed: 20524866
Bressenot A, Cahn V, Danese S et al (2014) Microscopic features of colorectal neoplasia in IBDs. World J Gastroenterol 20(12):3164–3172
doi: 10.3748/wjg.v20.i12.3164
Odze RD (2006) Pathology of dysplasia and cancer in IBD. Gastroenterol Clin N Am 35(3):533–552
doi: 10.1016/j.gtc.2006.07.007
Bossard C, Denis MG, Bézieau S et al (2007) Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncol Rep 18(5):1093–1097
pubmed: 17914558
Srivastava A, Redston M, Farraye FA et al (2008) Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 32(2):296–303
doi: 10.1097/PAS.0b013e318150d51b
Jackson WE, Achkar JP, Macaron C et al (2016) The significance of sessile serrated polyps in inflammatory bowel disease. Inflamm Bowel Dis 22(9):2213–2220
doi: 10.1097/MIB.0000000000000895
Fleiss J (1981) Statistical methods for rates and proportions. Wiley, New York, p 13
Landis J, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
doi: 10.2307/2529310
Altman D (1991) Practical statistics for medical research. Chapman and Hall, London
Feinstein AR, Cicchetti DV (1990) High agreement but low kappa: the problems of two paradoxes. J Clin Epidemiol 43(6):543–549
doi: 10.1016/0895-4356(90)90158-L
Cicchetti DV, Feinstein AR (1990) High agreement but low Kappa: II. Resolving the paradoxes. J Clin Epidemiol 43(6):551–558
doi: 10.1016/0895-4356(90)90159-M
Eaden J, Abrams K, McKay H et al (2001) Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 194(2):152–157
doi: 10.1002/path.876
Allende D, Elmessiry M, Hao W et al (2014) Inter-observer and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings [published correction appears in Colorectal Dis. 2015;17(1):92. Al-Qadasi, M [added]]. Colorectal Dis 16(9):710–718
doi: 10.1111/codi.12667
Odze RD, Goldblum J, Noffsinger A et al (2002) Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol 15(4):379–386
doi: 10.1038/modpathol.3880534
Odze RD, Tomaszewski JE, Furth EE et al (2006) Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 16(5):1123–1129
pubmed: 17016603
Wu XR, Liu HS, Shi XY et al (2018) Interobserver agreement in the diagnosis of inflammatory bowel disease-associated neoplasia in China in comparison to subspecialized American Gastrointestinal Pathologists. Gastroenterol Res Pract 2018:8715263
doi: 10.1155/2018/8715263
Van der Wel MJ, Coleman HG, Bergman JJGHM et al (2020) Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett’s dysplasia using digital pathology. Gut 69(5):811–822
doi: 10.1136/gutjnl-2019-318985
Weinstein RS, Bhattacharyya AK, Graham AR et al (1997) Telepathology: a ten-year progress report. Hum Pathol 28:1–7
doi: 10.1016/S0046-8177(97)90270-7
Villanacci V, Baronchelli C, Manenti S et al (2019) Serrated lesions of the colon. A window on a more clear classification. Ann Diagn Pathol 41:8–13
doi: 10.1016/j.anndiagpath.2019.05.006